Webinar – Hidden Potential: Using Fragments to Uncover New Ligandable Sites on Popular Targets

Learn how fragments reveal novel opportunities in well-known drug targets. Watch the webinar to explore strategies, case studies, and actionable insights.

How to target RNA modulation with small molecule?

In this two-part free webinar series, we've assembled a team of leading experts who will delve into the intricacies of RNA modulation, explore its potential applications, and showcase real-world case studies.

[EN] Kinase Inhibitors for Inflammatory Diseases: Preclinical Development

Join the featured speakers for an informative webinar on unlocking the synergy in preclinical models and the importance of target validation for the personalized treatment of pancreatic cancer.

[EN] Preclinical Models for the Identification of Chemotherapy Predictive Signatures in Pancreatic Cancer

Join the featured speakers to learn how they utilized preclinical models such as primary cell cultures, patient-derived xenografts, and patient-derived organoids to develop unbiased predictive RNA-based signatures.

Fragment-Based Drug Discovery — Hitting Targets Using the Right Chemistry and Expertise Alliances

Learn about Fragment-Based Drug Discovery (FBDD) and its Applications in our Webinar with leading experts from the field of FBDD.

[EN] How to Better Optimize an Oncology Drug Discovery Program

Watch this oncology webinar on preclinical pharmacology, covering all step of the drug discovery journey from target validation to clinical studies...

Preclinical Models for Microbiome Research in Oncology and Inflammatory Diseases

Learn how current in vivo preclinical models meet the needs of microbiome research and innovation while outlining their limitations and the challenges still to be overcome in this growing field.

[EN] How Rodent and NHP Models Support COVID-19 Treatment Development

Learn how to select the most appropriate COVID-19 animal model for preclinical studies in this webinar

[EN] Establishing an Expert Network for Your Radiopharmaceutical Drug Development Program

Learn how the DRIVE-MRT solution enables the rationalization, design & optimization of targeted & effective radiopharmaceuticals against specific cancers.

[EN] Oncology and Immuno-Oncology Precision Medicine: From Hit-Finding to Pre-Clinical Candidate Selection

Novel approaches in drug discovery using innovative models (PDX & PDX-derived models) to better mimic the situation of the human cancer pathologies.

[EN] Cancer Vaccine toolbox: innovative strategies for prophylactic or therapeutic vaccines

[EN] How do we keep you in the race of COVID-19?